Okay. The working group for the OECD proposed valuating these dose equivalents at $6.72 U.S., which is $8.40 Canadian under the current exchange rate of roughly 80 U.S. cents per Canadian dollar. I take it that the G7 equivalency is different from the OECD working group equivalency. Is that correct?
On March 21st, 2022. See this statement in context.